∗Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK;†National Cancer Intelligence Network (NCIN), London, UK;‡Royal Berkshire NHS Trust, Reading, UK;§Oxford Cancer Intelligence Unit, Oxford, UK
Abstract:
The use of chemotherapy in the treatment of prostate cancer is a relatively recent development, with no published data on the patterns of care in the UK. We carried out a population-based study to assess variation in the use of prostate cancer chemotherapy over time in a UK cancer network.